Related references
Note: Only part of the references are listed.Autoimmunity, dendritic cells and relevance for Parkinson's disease
E. Koutsilieri et al.
JOURNAL OF NEURAL TRANSMISSION (2013)
Neuromelanin enhances the toxicity of α-synuclein in SK-N-SH cells
Jie Li et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
The Role of Alpha-Synuclein in Melanin Synthesis in Melanoma and Dopaminergic Neuronal Cells
Tianhong Pan et al.
PLOS ONE (2012)
Neuromelanin is an immune stimulator for dendritic cells in vitro
Uwe Oberlaender et al.
BMC NEUROSCIENCE (2011)
Magnetic beads method for determination of binding of drugs to melanin
Michal Piotr Marszall et al.
JOURNAL OF CHROMATOGRAPHY A (2011)
Increase expression of α-synuclein in aged human brain associated with neuromelanin accumulation
Qi Xuan et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Meta-analysis of the relationship between Parkinson disease and melanoma
Rui Liu et al.
NEUROLOGY (2011)
Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson's Disease
Wei Zhang et al.
NEUROTOXICITY RESEARCH (2011)
Increased Melanoma Risk in Parkinson Disease A Prospective Clinicopathological Study
John M. Bertoni et al.
ARCHIVES OF NEUROLOGY (2010)
Anti-melanin antibodies are increased in sera in Parkinson's disease
K. L. Double et al.
EXPERIMENTAL NEUROLOGY (2009)
Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys
Luping Z. Huang et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Melanin-Targeted Preclinical PET Imaging of Melanoma Metastasis
Gang Ren et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Pigmentation genes link Parkinson's disease to melanoma, opening a window on both etiologies
Elena Herrero Hernandez
MEDICAL HYPOTHESES (2009)
THE ALS/PDC SYNDROME OF GUAM AND THE CYCAD HYPOTHESIS
Amy R. Borenstein et al.
NEUROLOGY (2009)
Family history of melanoma and Parkinson disease risk
X. Gao et al.
NEUROLOGY (2009)
Retention of the cyanobacterial neurotoxin β-N-methylamino-l-alanine in melanin and neuromelanin-containing cells - a possible link between Parkinson-dementia complex and pigmentary retinopathy
Oskar Karlsson et al.
PIGMENT CELL & MELANOMA RESEARCH (2009)
Current challenges in understanding melanogenesis: bridging chemistry, biological control, morphology, and function
John D. Simon et al.
PIGMENT CELL & MELANOMA RESEARCH (2009)
Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease
Luigi Zecca et al.
ACTA NEUROPATHOLOGICA (2008)
Complete ascertainment of Parkinson disease in the Swedish Twin Registry
Karin Wirdefeldt et al.
NEUROBIOLOGY OF AGING (2008)
The ALS/PDC syndrome of Guam and the cycad hypothesis
John C. Steele et al.
NEUROLOGY (2008)
Chemistry of mixed melanogenesis - Pivotal roles of dopaquinone
Shosuke Ito et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2008)
Chloroquine retinopathy: lipofuscin- and melanin-related fundus autofluorescence, optical coherence tomography and multifocal electroretinography
Ulrich Kellner et al.
DOCUMENTA OPHTHALMOLOGICA (2008)
Characterization of melanin in human iridal and choroidal melanocytes from eyes with various colored irides
Kazumasa Wakamatsu et al.
PIGMENT CELL & MELANOMA RESEARCH (2008)
Genes and the environment in neurodegeneration
Fabio Coppede et al.
BIOSCIENCE REPORTS (2006)
Evidence for specific phases in the development of human neuromelanin
G. M. Halliday et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
Evidence for specific phases in the development of human neuromelanin
H Fedorow et al.
NEUROBIOLOGY OF AGING (2006)
Epidemiology of Parkinson's disease
Lonneke M. L. de Lau et al.
LANCET NEUROLOGY (2006)
α-Synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease
GM Halliday et al.
BRAIN (2005)
Tyrosinase exacerbates dopamine toxicity but is not genetically associated with Parkinson's disease
E Greggio et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates
R Tzekov
DOCUMENTA OPHTHALMOLOGICA (2005)
Aging of the nigrostriatal system in the squirrel monkey
AL McCormack et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2004)
Long-term retention of neurotoxic β-carbolines in brain neuromelanin
A Östergren et al.
JOURNAL OF NEURAL TRANSMISSION (2004)
Neuromelanin inhibits enzymatic activity of 26S proteasome in human dopaminergic SH-SY5Y cells
M Shamoto-Nagai et al.
JOURNAL OF NEURAL TRANSMISSION (2004)
Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease
BA Faucheux et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Biomagnification of cycad neurotoxins in flying foxes - Implications for ALS-PDC in Guam
SA Banack et al.
NEUROLOGY (2003)
The structure of neuromelanin as studied by chemical degradative methods
K Wakamatsu et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Iron-binding characteristics of neuromelanin of the human substantia nigra
KL Double et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: Changing incidence rates during the past 60 years
CC Plato et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics
L Zecca et al.
TRENDS IN NEUROSCIENCES (2003)
Retinal pigment epithelium melanin and ocular toxicity
P Dayhaw-Barker
INTERNATIONAL JOURNAL OF TOXICOLOGY (2002)
ALS and PDC of Guam - Forty-year follow-up
CC Plato et al.
NEUROLOGY (2002)
Applications of affinity chromatography to the study of drug-melanin binding interactions
AF Aubry
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2002)
Overexpression of human α-synuclein causes dopamine neuron death in primary human mesencephalic culture
WB Zhou et al.
BRAIN RESEARCH (2002)
The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease
L Zecca et al.
FEBS LETTERS (2002)
Amphetamine adducts of melanin intermediates demonstrated by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
DJ Claffey et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2001)
Neurochemical findings in the MPTP model of Parkinson's disease
N Schmidt et al.
JOURNAL OF NEURAL TRANSMISSION (2001)
The parkinsonian models: Invertebrates to mammals
Y Kitamura et al.
JAPANESE JOURNAL OF PHARMACOLOGY (2000)
Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles
D Sulzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
